H-L-Asp(tBu)-OMe*HCl

H-L-Asp(tBu)-OMe*HCl is a protected L-aspartic acid derivative presented as a hydrochloride salt, featuring an L-configured α-amino acid backbone with a side-chain β-carboxyl group masked as a tert-butyl ester and a C-terminal methyl ester (OMe). The molecule contains a stereogenic center at the α-carbon and incorporates acid-labile and base-labile protection logic: the tBu ester on the side-chain carboxyl is typically removed under acidic conditions, while the methyl ester can be transformed through standard ester hydrolysis or transesterification strategies. Salt formation with HCl improves handling of the amino functionality for peptide coupling workflows and can influence solubility in polar organic media. The functional group set supports conversion into peptide building blocks, side-chain carboxyl activation for amide formation, and downstream synthesis of aspartate-containing analogs used in structure-guided molecular design and process chemistry intermediate preparation.

1. Peptide Synthesis

H-L-Asp(tBu)-OMe*HCl is used in peptide building block preparation where the α-amino group and protected carboxyl functionalities enable controlled peptide coupling chemistry. The L-aspartate framework with a C-terminal methyl ester and a β-carboxyl tert-butyl ester supports orthogonal protection patterns that help manage sequential N- and side-chain derivatization during stepwise assembly. Acid-labile removal of the tBu ester can reveal the side-chain carboxyl for subsequent activation and coupling, while ester functionality can be converted to an acid or activated derivative depending on the coupling strategy. Downstream, the resulting aspartate-containing peptide fragments and protected intermediates can be assembled into peptides and peptidomimetic scaffolds for biochemical research and synthetic organic chemistry campaigns.

2. Side-Chain Functionalization

H-L-Asp(tBu)-OMe*HCl serves as a practical substrate for β-carboxyl side-chain functionalization workflows that require stereochemically defined aspartate chemistry. The tert-butyl ester on the side-chain carboxyl provides a protected handle that can be selectively deprotected to generate a reactive carboxylic acid for amide bond formation, esterification, or further derivatization into activated intermediates. The methyl ester at the C-terminus can be hydrolyzed or transesterified to tune reactivity toward subsequent coupling steps or to prepare carboxylate-bearing analogs for library synthesis. Functionalized aspartate derivatives prepared from this scaffold can be used to generate structure-activity relationship (SAR) probes, create constrained peptide analogs, and supply downstream intermediates for fine chemical synthesis.

3. Protected Amino Acids

H-L-Asp(tBu)-OMe*HCl is suitable for protected amino acid chemistry where orthogonal protection and salt-form handling support reproducible peptide coupling and intermediate isolation. The combination of an acid-labile tert-butyl ester and a methyl ester provides a defined set of transformation points for protecting-group strategy planning across multi-step syntheses. Hydrochloride salt formation helps maintain the amino group in a reactive, manageable state for conversion into activated coupling partners or for incorporation into protected peptide sequences. The resulting protected aspartate intermediates can be applied to peptide building block preparation, automated synthesis compatibility assessments, and manufacturing route development for amino acid derivative supply chains.

4. SAR Studies

H-L-Asp(tBu)-OMe*HCl can be applied in SAR studies and molecular scaffold generation where aspartate side-chain geometry and carboxyl functionality are used to tune binding interactions. The L-stereochemistry and protected β-carboxyl group enable controlled synthesis of aspartate-containing analogs that can be diversified through deprotection followed by activation and coupling to varied nucleophiles. The presence of both an ester and a protected side-chain carboxyl supports systematic variation of polar functionality, enabling synthesis of analog series with defined functional group patterns. Downstream derivatives prepared from this intermediate can feed medicinal chemistry-style library construction, peptidomimetic optimization, and biochemical assay material generation.

5. Pharmaceutical Manufacturing

H-L-Asp(tBu)-OMe*HCl is relevant to pharmaceutical manufacturing and process chemistry intermediate preparation where protected amino acid inputs are integrated into scalable peptide and peptidomimetic production routes. The tert-butyl ester protection strategy supports acid-triggered deprotection steps that can be aligned with industrial process design, while the methyl ester functionality can be converted to carboxylic acid forms needed for downstream activation and coupling. Hydrochloride salt form can improve handling characteristics during batch processing and can be leveraged in solvent selection and purification planning for amino acid derivative manufacturing. The compound's defined stereochemistry and functional group reactivity enable consistent incorporation into aspartate-containing intermediates used for bulk synthesis of peptide-derived materials and specialty chemical production.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore